Kamada KMDA
NASDAQ KMDA
$8.31 +0.11 (+1.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kamada (KMDA) Cash & Current Investments (2012 - 2026)

Updated

Kamada (KMDA) recorded Cash & Current Investments of $70.13 million in the quarter ended Jun 30, 2026, up 6.3% from $65.99 million a year earlier but down 4.1% from the prior quarter.

Analysis

Kamada (KMDA) Cash & Current Investments (2012 - 2026) Analysis & Trends

As of Dec 31, 2025, Kamada reported Cash & Current Investments of $75.67 million, down 3.6% from the prior year.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of -7.1% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Cash & Current Investments came in at $78.48 million in the year ended Dec 31, 2024 (+40.7%), $55.78 million in the year ended Dec 31, 2023 (+62.8%), $34.26 million in the year ended Dec 31, 2022 (+83.6%) and $18.66 million in the year ended Dec 31, 2021 (-82.9%).
  • Quarterly Cash & Current Investments has ranged from $29,933 in the quarter ended Jun 30, 2022 to $99.84 million in the quarter ended Sep 30, 2021 over the past five years.
  • On a year-over-year basis, Cash & Current Investments rose in five of the last eight quarters, with growth averaging 18.9%.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 159.5% in the quarter ended Jun 30, 2024, against a decline of 100.0% in the quarter ended Jun 30, 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $73.15 million (quarter ended Mar 31, 2026), $75.67 million (quarter ended Dec 31, 2025) and $72 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Kamada 479.37 Mn 188.43 Mn 22.47 Mn 70.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 70.13 Mn
Mar 31, 2026 73.15 Mn
Dec 31, 2025 75.67 Mn
Sep 30, 2025 72.00 Mn
Jun 30, 2025 65.99 Mn
Mar 31, 2025 76.25 Mn
Dec 31, 2024 78.48 Mn
Sep 30, 2024 72.00 Mn
Jun 30, 2024 56.55 Mn
Mar 31, 2024 48.19 Mn
Dec 31, 2023 55.78 Mn
Sep 30, 2023 52.60 Mn
Jun 30, 2023 21.79 Mn
Mar 31, 2023 27.12 Mn
Dec 31, 2022 34.26 Mn
Sep 30, 2022 31.25 Mn
Jun 30, 2022 29,933.00
Mar 31, 2022 21.97 Mn
Dec 31, 2021 18.66 Mn
Sep 30, 2021 99.84 Mn
API Access

Kamada Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=KMDA&period=max&api_key=YOUR_API_KEY